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The retinoblastoma protein (Rb) and the homologous pocket proteins p107 and p130
negatively  regulate  cell  proliferation  by  binding  and  inhibiting  members  of  the  E2F
transcription  factor  family.  The  structural  features  that  distinguish  Rb  from the  other
pocket  proteins  have  been  unclear  but  are  critical  for  understanding  their  functional
diversity and determining why Rb has unique tumor suppressor activities.  We describe
here important differences in how the Rb and p107 C-terminal domains (CTD) associate
with the coiled-coil and marked-box domains (CM) of E2Fs.  We find that while CTD-CM
binding  is  conserved  across  protein  families,  the  Rb  and  p107  CTDs  show  clear
preferences for different E2Fs.  A crystal structure of the p107 CTD bound to E2F5 and its
dimer partner DP1 reveals the molecular basis for pocket protein-E2F binding specificity
and how Cyclin-dependent  kinases  differentially  regulate  pocket  proteins  through CTD
phosphorylation.  Our structural and biochemical data together with phylogenetic analyses
of Rb and E2F proteins support the conclusion that Rb evolved specific structural motifs
that confer its unique capacity to bind with high affinity those E2Fs that are the most
potent activators of the cell cycle.
Significance Statement
The retinoblastoma (Rb) pocket protein and E2F transcription factor families regulate
cell  division  and are  commonly  deregulated  in  proliferating  cancer  cells.  An  important
question has been what distinguishing molecular features of Rb and its interaction with E2F
result in its unique potency as a tumor suppressor relative to the homologous proteins
p107 and p130.  Here we identify structures in Rb, p107, and E2Fs that determine the
specificity in their association.  We explain binding preferences with a novel x-ray crystal
structure of a p107-E2F5-DP1 complex, and we present the first phylogenetic analyses that
implicate co-evolving protein interactions between family members as a key determinant
of their evolution. 
\body
Introduction
E2F transcription factors regulate the mammalian cell cycle by controlling expression
of genes required for DNA synthesis and cell division (1).  E2F activity is regulated by the
retinoblastoma (Rb) “pocket” protein family members Rb, p107, and p130, which bind and
inhibit E2F and recruit repressive factors to E2F-driven promoters (2-5).  Beyond cell-cycle
regulation, these pocket protein-E2F complexes are the focal point of signaling pathways
that  trigger diverse cellular  processes  including proliferation,  differentiation,  apoptosis,
and stress response.  Improper inactivation of pocket proteins is a common mechanism by
which  cancerous  cells  maintain  aberrant  proliferation  (1,  5-7).  Pocket  protein-E2F
dissociation  and  subsequent  E2F  activation  is  induced  by  cyclin-dependent  kinase
phosphorylation (3-5, 8) or binding of viral oncoproteins such as the SV40 T-antigen (9).
The E2F family contains eight members, five of which (E2F1-E2F5) form complexes with
pocket proteins (1).  E2F1-E2F3 associate exclusively with Rb and are potent activators of
transcription during the G1 and S phases of the cell cycle  (10, 11).  These “activating”
E2Fs also specifically induce apoptosis  (12).  E2F4 is found in complexes with all three
pocket proteins and is thought of primarily as a repressor, because it typically occupies
promoters of repressed genes and is exported from the nucleus upon release from pocket
proteins  (1,  13,  14).  In  contrast,  several  studies of  E2F4 function during development
suggest  that  E2F4  may  stimulate  proliferation  in  certain  contexts,  acting  through
association with other transcription factors (14). Better characterization of how E2F4 and
E2F5  associate  with  pocket  proteins  and  other  factors  is  needed  to  understand  their
different functions and how they are regulated.
 While all three pocket proteins similarly inhibit the cell cycle and proliferation, genetic
observations  suggest  important  distinct  functions.  For  example,  only  Rb  deletion  is
embryonic lethal in the mouse  (3, 15). Rb is a more potent tumor suppressor in mouse
cancer models (3, 15), and mutations are more commonly observed in human cancers (6,
16).  One proposed explanation for these observations is that Rb forms unique complexes
with  the  activating  E2Fs  (E2F1-E2F3),  although  other  pocket  protein-specific  binding
interactions may confer distinct functions  (4, 17).  For example, through unique protein
interactions,  Rb functions in processes outside of cell-cycle control  including apoptosis,
chromosome stability, transcriptional silencing, and metabolic regulation (5, 18). 
 The five canonical E2Fs each contain a DNA binding domain (DBD), a transactivation
domain (TAD), and a coiled-coil and marked-box domain (CM) (Fig. 1A).  The DBDs are
homologous  and  bind  similar  DNA  sequences  as  heterodimers  with  one  of  three  DP
proteins (1). The CM domain of E2F also heterodimerizes with a similar domain in DP (19),
and the CM heterodimer binds other transcription factors as a proposed mechanism for
how specific E2F family members activate distinct genes (20, 21).  The Rb family pocket
domains bind the E2F transactivation domain and bind other cellular and viral proteins
using a distinct surface called the LxCxE-cleft (4, 17) (Fig. 1A).  Each pocket protein also
contains  a  C-terminal  domain  (CTD)  that  is  required  for  growth  suppression  and  E2F
inhibition and has a role in protein stability (22-24). A crystal structure demonstrates that
the Rb CTD (RbC) binds the E2F1-DP1 CM domains (19), but several studies suggest that
this particular association may be specific to Rb and E2F1 (25, 26). 
To  better  understand  how  the  Rb  proteins  regulate  E2F  function,  we  have
characterized  the  association  of  pocket  protein  CTDs  with  the  E2F  CM domain.   We
determined crystal structures of the E2F4-DP1 CM domain (E2F4-DP1CM) and E2F5-DP1CM in
complex with the p107 CTD (p107C).  The structure of the ternary complex clarifies the
generality of this domain association among all  family members and reveals molecular
details that explain the respective preferences of activating E2Fs for Rb and repressive
E2Fs for p107 and p130 (p107/p130).  We conclude that Rb evolved sequences that make
it uniquely suited to bind and regulate the activating E2Fs.  Our combination of structural
and  biochemical  data  with  phylogenetic  analyses  provides  novel  insights  into  the  co-
evolution of a protein-protein interaction critical for control of cell proliferation.
Results
Distinct E2F-binding properties of RbC and p107C
We first tested whether the binding preferences of Rb pocket proteins for different E2F
family members result from different affinities between the pocket protein CTDs and E2F
CM domains (Fig.  1B and 1C).  We used a co-precipitation assay to identify a minimal
fragment of p107C (residues 994-1031, called p107C994-1031) that is suitable for structural
studies and is sufficient to bind E2F4-DP1CM (Fig. S1). Using isothermal titration calorimetry
(ITC) (Fig. 1C), we found that p107C994-1031 binds with similar affinity as that previously
reported for full-length p107C (residues 949-1068) (19). Both p107C994-1031 and p107C949-1068
bind  E2F1-DP1CM with  lower  affinity  than  they  bind  E2F4-DP1CM.  These  affinity
measurements performed with purified protein fragments are  consistent  with  previous
observations of interaction specificities among Rb and E2F family proteins in cells and
suggest that these specificities arise at least in part from intrinsic structural differences (1,
10-13).
Comparing these measurements with previous measurements of RbC reveals several
differences between how RbC and p107C bind to E2F-DPCM domains (Fig. 1C) (19).  First,
the affinity of the full RbC sequence (residues 771-928) is four-fold tighter than full p107C
for E2F4-DP1 and fifty-fold tighter for E2F1-DP1.  Second, while RbC makes a bipartite
association  with  contributions  from  residues  786-801  (RbCnter)  and  residues  829-864
(RbCcore) (Fig. 1B) (19), all the interactions made by p107C are contained within p107C994-
1031 (p107Ccore).  Third, while RbCcore has similar affinity for E2F1 and E2F4 (19), p107Ccore
has higher affinity for E2F4 than E2F1.  We next determined the structural basis for these
affinity differences.
Conservation of E2F-DP CM structures
 We grew crystals of E2F4-DP1CM alone and E2F5-DP1CM bound with p107C994-1031 and
determined structures with resolution of 2.3 Å and 2.9 Å respectively (Table S1 and Fig. 2).
In  both  structures,  the  E2F  and  DP  polypeptides  have  similar  secondary  structure
topology, and the chains entwine to create an extensive interface (Fig. 1B and 2A). The CM
structure consists mainly of a heterodimeric coiled-coil subdomain and a heterodimeric -
sandwich subdomain that are bridged by two small helices and two small strands. The
intertwined structure and dependence on DP to complete the hydrophobic core explain
why heterodimerization is necessary for E2F stability,  DNA binding,  and transcriptional
activity (1, 19).
We  considered  sequence  and  structural  conservation  among  E2F  paralogs  and
identified regions  in  the  coiled-coil  and  marked-box domains  that  may be  involved  in
shared or distinct functions.  Several aspects of the E2F4-DP1CM and E2F5-DP1CM structures
are  similar  to  the  previously  determined  structure  of  E2F1-DP1CM (19), including  the
topology  and  structures  of  the  -sandwich  domains  (Fig.  S2).   One  notable  variation
among the structures is the orientation of the coiled-coil domain relative to the -sandwich
domain (Fig. 2B).  Alignment of the overall structures with the  -domain fixed suggests
that the coiled-coil domain can pivot about a fixed contact point made with the 2 helix in
DP1.  Considering that the E2F-DP DNA binding domains are N-terminal to the start of the
coiled-coil  domain,  we  suggest  that  this  flexibility  may  be  important  for  bridging  the
interaction with DNA and interactions with other transcription factors that potentially bind
the marked-box domain or C-terminal regions in E2F (20, 21). 
Sequence comparison of the human E2Fs reveals that twenty residues are identical
within the CM domain (Fig. 1B). They map primarily to the coiled-coil interface and the
structural  core  that  bridges the  -sandwich and coiled-coil  domains (Fig.  S2E).   These
amino  acids  contribute  to  the  overall  stability  of  the  E2F-DP  heterodimer.  The  most
notable region of the structure that is distinct among paralogs is the end of E2F 3 and the
loop between  3 and  4.  We explore below the idea that sequence divergence in this
region accounts for differences in specificity for different pocket proteins.  
Specificity in Rb and p107 interactions with E2F-DPCM 
p107C binds the E2F5-DP1 marked-box domain using a strand-loop-helix motif (Fig. 2
and  Fig.  3A).   The  strand  adds  on  in  an  anti-parallel  direction  to  the  -sheet  in  the
immunoglobulin sandwich domain that is distal to the coiled coil. The amphipathic p107C
helix covers the core of the -sandwich domain (Fig. 3A).  The hydrophobic sidechains of
L1014, I1017, M1020, and I1021 from p107C pack into the core.   They make van der
Waals contacts with L198, V200, I202, and P203 from E2F5 and I262, T290, F291, I293,
and D295 from DP1. These residues in E2F5 are all conserved in E2F4 (Fig. 1B), and we
anticipate that E2F4 binds p107 through identical interactions.  
 We  used  the  Cancer  Genome  Atlas  (cancergenome.nih.gov)  to  identify  cancer-
associated mutations in p107 and p130 that are localized to the CTD.  We mapped these
mutations onto the p107C-E2F5-DP1 crystal structure and tested their effects on binding
with ITC (Fig. S3). We conclude that most of these cancer-associated mutations map to the
exposed surface of the CTD helix and only slightly impair the ability of p107 to bind E2F.
We compared our structure of the p107C-E2F5-DP1 complex with the structure of the
RbC-E2F1-DP1 complex to understand the binding preferences revealed by our affinity
measurements.  First we addressed the question of why E2F4-DP1 has higher affinity for
p107Ccore than RbCcore (Fig.  1C).  In  general,  the mode of  RbC binding to the E2F1-DP1
marked-box domain resembles p107C binding to E2F5-DP1 (Fig. 3)  (19).  However,  the
contacts between hydrophobic residues near the N-terminus of the helix and C-terminus of
the strand are distinct with V833, I835, T841, and F845 in Rb replaced with Y1004, F1006,
and L1014 in p107 (Fig. 3B). We suggest that tighter packing of this interface stabilizes
p107C binding relative to RbC.
 A second observed binding specificity is the higher affinity of p107C for E2F4 and E2F5
compared  to  E2F1  (Fig.  3D).  To  understand  this  preference,  we  considered  residues
towards the C-terminus of strand 3 in the E2F5 structure (residues 200-203).  In addition
to  L198,  which  is  conserved  among  all  E2Fs,  these  residues  contain  the  only  E2F
sidechains that directly contact p107C, and they are different between E2F5 and E2F1.
The sequence in E2F5 and E2F4 is VPIP, while the sequence in E2F1 is AVDS (Fig. 1B and
3C).  The bulkier V200 in E2F5 (V167 in E2F4) can interact better with I1017 and M1020 in
p107 compared to the smaller A275 in E2F1 (Fig. 3C).  In addition, P201 in E2F5 (P168 in
E2F4) causes the strand to bulge such that P203 (P170 in E2F4) is in position to contact
I1021.  D277 in E2F1 is at the same position as P203 in E2F5 and likely makes weaker
interactions.  
We used the calorimetry assay to test the importance of the E2F4/E2F5-conserved VPIP
motif  for  p107C994-1031 affinity  (Fig.  3D).   We  primarily  used  E2F4  in  our  binding
measurements  because  E2F4  is  more  abundant  in  cells  and  expresses  well  as  a
recombinant  protein.  E2F4 and E2F5 are highly conserved in the  3-strand that  binds
p107C (Fig. 1B), and they both bind wild type p107C with similar affinity (Fig. 3D).  We
found that changing the VPIP sequence in E2F4 to the AVDS sequence in E2F1 yields a
mutant E2F4-DP1CM heterodimer that binds p107C nearly three-fold weaker than wild-type.
Conversely, mutation of the E2F1 AVDS sequence to VPIP increases the affinity of E2F1-
DP1CM for p107C994-1031 four-fold.   We also found that p107C994-1031 binds E2F3-DP1CM more
weakly than it binds E2F4-DP1CM and E2F5-DP1CM and more similar to how it binds E2F1-
DP1CM (Fig. 3D). Although E2F3 has the first proline to induce the bulge in the strand (Fig.
1B),  the  S331  at  the  position  of  the  second  proline  in  E2F4/E2F5  is  suboptimal  for
contacting I1021 (like D277 in E2F1).  Together these data demonstrate that the sequence
in 3 strand is a critical determinant for p107 binding repressive E2Fs with higher affinity
than activating E2Fs.
 Unlike p107, RbC binds E2F1-DP1CM and E2F4-DP1CM with similar affinity (Fig. 1C) (19).
Rb  contains  a  valine  (V852)  at  the  analogous  position  as  I1021  in  the  p107C  helix.
Structural alignment suggests that the smaller Rb sidechain would not contact P203 in
E2F5 (P170 in E2F4),  and we observe loss of  affinity  due to substitution of  the I1021
sidechain with a smaller hydrophobic group (Fig. S3).  The structural comparison suggests
the explanation that Rb is less sensitive to the differences in E2F1 and E2F4/E2F5 at this
binding interface because of the weaker interactions between V852 and the E2F 3 strand.
Additional  interactions  involving the RbCnter sequence enhance RbC binding to both
E2F1-DP1CM and E2F4-DP1CM (19).  In contrast, our measurements here suggest that the
sequence in p107 N-terminal to the core binding region in the crystal structure does not
make  these  stabilizing  interactions  (Fig.  1C).   We found that  replacing  the  p107C N-
terminal sequence (residues 949-974) with the RbCnter sequence (residues 771-822) results
in a hybrid p107C construct that binds E2F1-DP1CM and E2F4-DP1CM with increased affinity
compared to p107C994-1031 and p107C949-1068 (Fig. 3E).  This observation demonstrates that
the RbCnter sequence enables RbC to bind both activator and repressive E2F proteins with
higher affinity than p107C.
Although Rb is in complexes with both activating and repressive E2Fs,  it  has been
proposed that the RbC association is specific to E2F1 (11, 25, 26). We find here that RbC
binds different E2F-DPCM domains with similar affinity (Fig. 1C and Fig. S4).  As we discuss
further  in  Fig.  S4,  this  apparent  discrepancy  arises  from differences  in  the  affinity  of
different  E2F  transactivation  domains  for  the  Rb  pocket  domain.  In  contrast  to  Rb,
differences in affinity for both the transactivation domain (27) and the CM domain (Fig. 1C)
contribute to the preference of p107 for different E2Fs.  
T997 and S1009 phosphorylation regulates p107C binding to E2F-DPCM
We next  explored  the  question  of  how Cdk  phosphorylation  of  p107  weakens  the
p107C-E2F-DPCM association.  We phosphorylated the two Cdk sites in p107994-1031 (T997
and S1009, Fig. 1B) with purified Cdk2-CycA and found by ITC that the affinity of the
phosphorylated peptide was eleven-fold weaker than the unphosphorylated peptide (Fig.
4A).   We then made T997A and S1009A mutations in two separate constructs and found
that phosphorylation at the remaining site in each construct still weakens affinity. These
measurements demonstrate that both phosphorylation events in p107C inhibit binding to
E2F-DPCM and that their effects are additive.  
 In the crystal structure of the ternary complex, S1009 is visible in the loop between
the p107C strand and helix (Fig. 4B).  The loop folds back towards the secondary structure
elements, and the S1009 sidechain makes a hydrogen bond with S1013, which is in the
p107C helix.  Phosphorylation of S1009 likely weakens affinity by destabilizing this bound
conformation.  Electron density for T997 is not visible, suggesting that T997 is disordered.
It is less clear then why T997 phosphorylation inhibits the association.  
The phosphorylation  pattern within  the CTD of  p107 and p130 is  distinct  from the
pattern in Rb (Fig. 1B).  In Rb, there are two threonine Cdk sites (T821 and T826), but they
are both N-terminal to the CTD strand, and their phosphorylation does not directly inhibit
binding of RbCcore to E2F1-DP1 (19).  Instead, phosphorylation of these Rb sites induces an
interdomain  association  between  phosphorylated  RbC  and  the  pocket  domain,  which
competes with RbCcore  binding to E2F-DPCM. We found that phosphorylation of p107C T997
and  S1009  directly  inhibits  E2F-DPCM binding,  and  we  could  not  detect  binding  of
phosphorylated p107C to the p107 pocket domain. 
Rb sequence elements that confer E2F binding affinity co-evolved with E2F1 and
E2F2
Our data support the conclusion that Rb is unique among pocket proteins in its ability
to bind E2F1 with high affinity. To test the hypothesis that this property of Rb co-evolved
with E2F1, we examined the evolutionary history of pocket proteins and E2Fs along the
metazoan  lineage from a subset  of  52  genomes.  Our  phylogenetic  analysis  reveals  a
number of gene duplication events that resulted in the expansion of the pocket protein
and E2F families (Fig. 5, Fig. S5, Fig. S6, and Fig. S7).  In agreement with previous work
(28),  we find that  the divergence of  Rb and RbL (the p107/p130 ancestor)  from their
common  ancestor  (aRb)  precedes  the  emergence  of  Eumetazoa,  possibly  after  the
divergence of Choanoflagellata and before the emergence of the Placozoa lineage. This
emergence of Rb appears to coincide with the emergence of two E2F proteins, one that is
the ancestor of E2F4 and E2F5 (E2F45) and one that is the ancestor of E2F1, E2F2, E2F3
and E2F6 (E2F1236).   Additional  gene duplication  events  occurred  at  the base of  the
Craniata lineage after the divergence of the Agnantha lineage (“lamprey”),  when RbL2
(p130) and RbL1 (p107) emerged from RbL, E2F4 and E2F5 emerged from E2F45, and
E2F1, E2F2, E2F3, and E2F6 emerged from E2F1236.
We focused  on  the  evolution  of  structures  that  play  a  role  in  determining  pocket
protein-E2F binding specificity.  There is considerable conservation in the pocket protein
CTD helix (in human p107 residues 1011-1023), which plays a prominent role in binding
E2F-DPCM (Fig. 3).  For example, the helix residues along the interface are hydrophobic in
all  the sequences  dating back to the early  metazoa,  and several  positions are  nearly
strictly conserved (Fig. 6 and Fig. S8).  Two positions that give rise to differences in how
Rb binds the E2Fs--L1014 (F845 in human Rb) and I1021 (V852)--emerge in Rb in sharks
(Fig.  6  and  Fig.  S8).  This  emergence  is  coincident  with  the  expansion  of  the  protein
families at the base of the Craniata lineage (Fig. 5 and Fig. 6). 
 We also examined the sequence corresponding to the end of E2F β3 strand (V200-
P203 in human E2F5), which our data implicate as a key source of binding preferences
between the E2F and pocket  proteins (Fig.  3).   The ancestral  E2F at  the base of  the
phylogenetic tree and the two E2Fs in early metazoa (E2F45 and E2F1236) all contain the
VP*P motif at these positions (Fig. 6 and Fig. S8). This motif is kept in the E2F4 and E2F5
lineages through humans.  As seen in our E2F5 structure, the VP*P sequence places the
hydrophobic V200 and P203 sidechains at the interface with p107C, and these residues
are critical for high affinity binding of p107C to human E2F4-DP1CM (Fig. 3).  The VP*P motif
is eventually lost in all three activator E2F lineages.  It is lost first in E2F1 and E2F2, which
emerge in sharks and lack the first and second proline respectively (Fig. 6).  The E2F3
lineage maintains the VP*P motif until more recently diverged animals, in which it lacks
the second proline.  Notably, we observe that both human E2F1 and E2F3 have weaker
affinity for p107C than E2F4 and E2F5 (Fig. 3D).  Therefore, the unbiased approach that
groups E2Fs based on phylogenetic distance over their entire sequence (Fig. 5 and Fig. 6)
matches a grouping based on their affinity for p107C (Fig. 3D), which arises in large part
from sequence variation in just the four motif residues.
Our  phylogenetic  analyses  support  the  hypothesis  that  the  VP*P  motif  is  a  key
distinguishing  feature  between  activator  and  repressive  E2F  structure  and  function.
Examination of  the pocket  protein  CTD sequences  indicates  that  the RbCnter sequence
emerges at the same point as E2F1 and E2F2, despite the divergence of Rb from RbL
much earlier  in  the tree (Fig.  6 and Fig.  S8).   The Rb proteins from  C. mil and other
cartilaginous fish (L. eri and S. can) have sequences that resemble RbCnter, although they
lack  the  S788  (human  Rb  numbering)  Cdk  phosphorylation  site  (Fig.  S8).   The  first
complete RbCnter appears in vertebrates (e.g. D. rer). 
Our analysis suggests that the appearance of the E2F1-E2F3 lineages and loss of the
VP*P-motif are coincident with the appearance of the RbCnter sequence.  Loss of affinity
between RbL (p107/p130) and E2F1 and E2F2 is compensated by the gain in affinity of Rb
due  to  the  emergent  RbCnter sequence.   We  could  recapitulate  this  hypothesized
adaptation by adding RbCnter to p107C (Fig. 3E).  The hybrid protein has enhanced affinity
for E2F1 over p107C.  We see a similar trend in pocket residues that confer higher affinity
of Rb for activator E2F transactivation domains. For example, H555 and K475 (human Rb
numbering), both of which increase affinity of the Rb pocket domain for E2F2TD relative to
the affinity of the p107 pocket domain (27), emerge in sharks around the E2F1 and E2F2
emergence (Fig. S9). We propose that Rb has maintained sequence variations from its
ancestor that contribute to its high–affinity interactions with and ability to inhibit activator
E2Fs.
Discussion
Our  structural  and  biochemical  data  support  the  conclusion  that  the  association
between the pocket protein CTD and E2F-DPCM domain is a general binding mechanism
shared  by  all  pocket  proteins  and  canonical  E2F  family  members.  Functional  studies
clearly point to a unique role for Rb in regulating E2F1 activity, and it had been proposed
that  RbC has unique affinity for E2F1CM (11,  25,  26).   We demonstrate  here that RbC
associates similarly with different E2F CM domains, and we suggest that RbC-E2F1 binding
was thought to be specific because previous Rb-E2F1 co-immunoprecipitation experiments
detected a stronger pocket-E2F1 TAD association (19, 25-27) (Fig. S4). In contrast to RbC,
we find here that p107C binds E2F1CM and E2F3CM with weaker affinity than E2F4CM and
E2F5CM, and the crystal structure of the p107C complex offers a clear explanation for the
preference  for  the  repressor  E2Fs  (Fig.  3).   These  data  are  consistent  with  previous
observations that the p107C domain is required for its growth suppressive function and
that p107 associates exclusively with repressor E2Fs except when it is overexpressed (13,
24, 29).  We find that p107 has some capacity to bind all E2Fs, but its preference is tuned
by the molecular details of the p107C-E2FCM association.
Our phylogenetic analyses and examination of specific sequence motifs  involved in
pocket  protein-E2F  interactions  point  to  a  special  relationship  between  Rb  and  the
activating E2Fs.  The emergence of E2F1 and E2F2 is accompanied by the emergence of
Rb-specific sequences that result in higher E2F affinity. We propose that coincident with
the divergence of E2F1 and E2F2 from their ancestor and the accumulation of changes
that  weakened  p107/p130  binding,  Rb  underwent  adaptive  changes  that  resulted  in
increased E2F binding  affinity.   While  these  adaptive  changes  do not  result  in  higher
affinity specifically for E2F1 and E2F2, the foregoing poor affinity of p107 and p130 for
activator E2Fs rendered Rb the only pocket protein with high affinity for activating E2Fs.
We find it interesting that the RbCnter sequence includes a Cdk phosphorylation site that is
known to weaken RbC-E2F affinity (19).  We suggest that the additional E2F-binding motif
co-evolved with a regulatory mechanism such that Rb-E2F complexes can be dissociated.
Here we demonstrate that there are unique Rb structural  features that underlie its
exclusive ability to regulate activator E2Fs.  These observations complement and explain
previous studies that implicate E2F1, E2F2, and E2F3 activity as the cause of aberrant
phenotypes  in  Rb  knockout  cells  (30-33).   Rb  regulation  of  activator  E2Fs  cannot  be
complemented by p107/p130, because they fail  to bind with sufficient affinity. In more
complex  organisms  with  multiple  pocket  proteins  and  E2Fs,  exclusive  relationships
between family members may allow for independent regulation of different processes. For
example,  specific  Rb  inhibition  of  activating  E2Fs  is  likely  relevant  to  other  functions
beyond the cell cycle such as apoptosis or response to DNA damage  (1, 12). Our data
support the model that the unique role of Rb in development and tumor suppression arises
from its unique capacity to regulate the activator  E2Fs. At the same time, our results
indicate  that  p107/p130  have  some  weak  affinity  for  activating  E2Fs  that  may  be
exploited.  It has been observed that p107 represses E2F1 upon overexpression (29), and
endogenous  p107/p130  complexes  with  E2F1  or  E2F3  can  be  detected  in  mouse
fibroblasts  that  lack  E2F4  and  thus  have  higher  free  p107/p130  concentrations  (34).
Increasing p107/p130 association with the activator  E2Fs may be a viable therapeutic
strategy towards harnessing their activity to compensate for Rb loss.
Materials and Methods
Proteins  were  expressed and purified  using  standard  methods.   Crystallization  was
performed using vapor diffusion in sitting drops, and x-ray diffraction data were collected
at  the  Advanced  Photon  Source.   The  dimer  and  trimer  structures  were  solved  by
molecular replacement and single anomalous diffraction methods.  ITC experiments were
performed with a Microcal VP-ITC instrument, and the reported errors are the standard
deviations from two to four measurements.  Phosphorylation of p107C was performed as
previously  described  (27).  Profile-Hidden Markov Models  (profile-HMMs)  were  built  and
used  to  retrieve  E2F  and  pocket  protein  homologs.  Following  sequence  alignment,
phylogenetic analysis was performed using maximum-likelihood methods.  Details of all
experimental procedures can be found in Supplemental Materials and Methods.
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Figure Captions
Fig. 1. Interactions between pocket protein C-terminal domains (CTDs) and the
E2F coiled-coil  and marked-box (CM) domains.  (A) Domain architecture of  pocket
proteins, E2F, and DP. The E2F transactivation domain binds the pocket domain, and the
E2F-DP CM domain binds the CTD.  (B) Sequence alignment of the human E2F CM domains
and  pocket  protein  CTDs.  The  secondary  structure  elements  present  in  our  crystal
structures  are  indicated  along  with  residues  in  E2F5  (*)  that  contact  the  p107  CTD
(p107C). Cdk phosphorylation sites are indicated with blue dashed lines. (C) Calorimetry
measurements of RbC and p107C binding to E2F-DP CM domains. p107994-1031 binding was
measured here, whereas the other values were previously reported  (19).  The asterisk
indicates that the previous measurement was made with E2F4-DP2CM.
Fig. 2. Crystal structures of the E2F4-DP1 and E2F5-DP1 CM domains.  (A) Overall
structures  show  similar  topologies  with  the  E2F  and  DP  chains  forming  an  extensive
interface. (B) Overlay of the CM domain structures determined for E2F1-DP1 (grey, PDB:
2AZE), E2F4-DP1 (pink), and E2F5-DP1 (red and purple correspond to the two different
molecules in the asymmetric unit). Structures were overlaid by alignment of  -sandwich
domain C atoms (Fig. S2)  so that the different positions of the coiled-coil domains reflect
their different orientations relative to the -sandwich domain. Only the -sandwich domain
of E2F1-DP1 is shown. 
Fig. 3. Comparison of p107C-E2F5 and RbC-E2F1 binding interfaces.  (A) p107C
binds  the  E2F5-DP1  -sandwich  domain  using  a  strand-loop-helix  motif  and  forms  a
hydrophobic interface with residues from both E2F and DP.  (B) Overlay of RbC (taken from
the RbC-E2F1 structure) with p107C models how RbC would bind E2F5. (C) Overlay of E2F1
and E2F5 models how p107C would bind E2F1.  (D) Affinity measurements for p107C994-1031
binding to the indicated E2F-DPCM domains.  The E2F4-DP1CM AVDS mutant has the E2F4
VPIP sequence (residues 167-170) mutated to AVDS, while the E2F1-DP1CM mutant has the
E2F1 AVDS sequence (residues 275-278) mutated to VPIP. (E) Affinity measurements of an
RbC-p107C hybrid protein containing residues 771-794 of Rb (RbCnter) fused to residues
975-1031 of p107.
Fig. 4.  Phosphorylation of Cdk sites in p107C directly inhibits E2F binding. (A)
ITC measurements of p107C peptides phosphorylated at the indicated sites.  (B) Structure
of the  p107C-E2F5-DP1 interface.
Fig.  5.  Phylogenetic  distribution  of  pocket  protein  and  E2F  sub-families.
Detected pocket  proteins and E2Fs from each genome are classified into sub-families
based on phylogenetic analysis (see Supplemental Methods). The resulting distribution of
homologs was condensed and ordered according to the current consensus on phylogenetic
relationships between major animal lineages (35), including alternative locations of the
Ctenophora (dashed grey line) and  with Amoebozoa as an outgroup. Common names of
exemplary species are in parenthesis.
Fig.  6.     Evolutionary  model  of  sequences involved in  E2FCM-pocket  protein
association.   Family members are arranged according to their phylogenetic distances
over their entire sequences. The VP*P motif in the E2F3 strand, hydrophobic residues in
RbCcore, and whether the RbCnter sequence is present are indicated. The amino acid number
of the last residue in each human sequence is shown.
 

